Emergent BioSolutions Inc (NYSE:EBS)

Monday’s trading has closed, but EBS is being traded in the after-hours session. After-Hours quote »
Data as of 4:02pm ET
 +0.16 / +0.56%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Emergent BioSolutions, Inc. is a biopharmaceutical company. It focuses on the research, development, and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. The company operates through two segments: Biodefense and Biosciences. The Biodefense segment focuses on vaccines and antibody therapies for use against the infectious disease anthrax. The Biosciences segment focuses on protein therapies to treat certain types of cancer and vaccines for use against infectious diseases. The company was founded in May 1998 and is headquartered in Rockville, MD.

Contact Information

Emergent BioSolutions, Inc.
2273 Research Boulevard
Rockville Maryland 20850
P:(301) 795-1800
Investor Relations:
(301) 795-1877



Other institutional40.16%
Mutual fund holders39.76%
Individual stakeholders30.02%

Top Executives

Daniel J. Abdun-NabiPresident, Chief Executive Officer & Director
Robert G. KramerCFO, Treasurer & Executive VP-Corporate Services
W. James JacksonChief Scientific Officer & Senior Vice President
Scott C. StromattChief Medical Officer & Senior Vice President
Adam R. HaveyExecutive VP & President-BioDefense Division

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.